insights_auto
Why is NVSEF up 2,28%?
Dive Deeperchevron_right
NVSEF:OTCMKTS
Novartis AG
US$143,18
arrow_upward
+2,28%(+3,20) 1D
12 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NVSEF...
Open
US$143,18
High
US$143,18
Low
US$143,18
Mkt. cap
292,13 ຕື້
Avg. vol.
30,94 ພັນ
Volume
351,00
52-wk high
US$171,29
52-wk low
US$120,00
Beta
0,40
Shares outstanding
2,03 ຕື້
No. of employees
75 ພັນ
Open
US$143,18
High
US$143,18
Low
US$143,18
Mkt. cap
292,13 ຕື້
Avg. vol.
30,94 ພັນ
Volume
351,00
52-wk high
US$171,29
52-wk low
US$120,00
Beta
0,40
Shares outstanding
2,03 ຕື້
No. of employees
75 ພັນ
News stories
From web sources and news partners
ad-hoc-news.de
·
1 ຊົ່ວໂມງກ່ອນ
Novartis stock pre-market at EUR 128.74
ad-hoc-news.de
·
2 ຊົ່ວໂມງກ່ອນ
DKSH expands Novartis partnership as seven analysts track DKSH stock
Forkast News
·
13 ຊົ່ວໂມງກ່ອນ
SAP’s Joule Assistants Are Now Executing Inside Production Business Workflows at Novartis, Nestlé, and PwC
marketscreener.com
·
14 ຊົ່ວໂມງກ່ອນ
Swiss Blue-chip Index Starts Week Upbeat; Roche, Novartis Shares Gain
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About Novartis AG
CEOVasant Narasimhan
Employees75,3 ພັນ
Founded7 ມ.ນ. 1996
Headquartersບາເຊວ, Basel City, ສະວິດເຊີແລນ
SectorPharmaceutical industry
Websitenovartis.com